2020. 12. 31, 코리아헤럴드
Dr. Rhee Chul-woo, a research scientist at the International Vaccine Institute, said in an email response that the mutations include “changes to the part of virus that plays an important role for the vaccine to be effective (i.e., receptor binding domain of spike protein).”
The “spike” protein is how the virus gains entry into human cells, he explained.
기사 보기 (영문) >>